RELMADA THERAPEUTICS, INC. financial data

Symbol
RLMD on Nasdaq
Location
Coral Gables, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 423% % -42%
Debt-to-equity 31% %
Return On Assets -205% % -83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73,333,622 shares 143%
Common Stock, Shares, Outstanding 33,191,622 shares 10%
Entity Public Float $89,007,030 USD 22%
Common Stock, Value, Issued $33,191 USD 10%
Weighted Average Number of Shares Outstanding, Basic 33,191,622 shares 10%
Weighted Average Number of Shares Outstanding, Diluted 33,191,622 shares 10%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $29,806,648 USD -40%
General and Administrative Expense $28,035,993 USD -33%
Operating Income (Loss) $57,842,641 USD 37%
Nonoperating Income (Expense) $1,668,102 USD -68%
Net Income (Loss) Attributable to Parent $56,174,539 USD 35%
Earnings Per Share, Basic -1 USD/shares 37%
Earnings Per Share, Diluted -1 USD/shares 37%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,384,484 USD -6.7%
Assets, Current $14,854,269 USD -73%
Other Assets, Noncurrent $21,975 USD 0%
Assets $14,876,244 USD -73%
Accounts Payable, Current $1,453,102 USD -38%
Accrued Liabilities, Current $3,736,496 USD -35%
Liabilities, Current $5,189,598 USD -36%
Liabilities $5,410,705 USD -33%
Retained Earnings (Accumulated Deficit) $678,399,438 USD -9%
Stockholders' Equity Attributable to Parent $9,465,539 USD -80%
Liabilities and Equity $14,876,244 USD -73%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $18,067,033 USD -39%
Net Cash Provided by (Used in) Financing Activities $221,747 USD
Net Cash Provided by (Used in) Investing Activities $15,359,713 USD 53%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 33,191,622 shares 10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,384,484 USD -6.7%
Deferred Tax Assets, Valuation Allowance $115,359,000 USD 4.7%
Preferred Stock, Shares Authorized 200,000,000 shares
Additional Paid in Capital $687,831,786 USD 2.7%
Share-based Payment Arrangement, Expense $4,478,000 USD -46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares